VYNE NASDAQ · Healthcare · FY 2025-12-31
VYNE Therapeutics Inc.
ABV
EPV
EBV
DBV
fair value / share
buy at or below (margin of safety applied)
margin-of-safety band
current price
values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○
Low · 1/4
Price
28.560 USD
Market cap
951.7M USD
P / B
34.28
P / E
—
EPS
-0.620
DPS / yield
20.121 (70.5%)
NAV / share
0.833
Graham number
—
Z'' score
-70.34
Piotroski F
2 / 9
Beneish M
—
ROIC vs WACC
-724.2%
vs 17.5%
See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.
Subscribe to unlock this and every other tab for every company.
See the full ABV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EPV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full DBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.